The Kos Renaissance Innovation Fund is a venture fund that invests in early, mid and late stage private companies in the biotechnology and life sciences space that are developing innovative breakthrough therapies and healthcare solutions in areas of significant unmet medical need.
The Kos Special Situations Fund invests in publicly traded companies in the biotechnology and pharmaceuticals space. We invest in companies that we view as significantly undervalued post price dislocation events that we believe create major arbitrage opportunities and asymmetrical risk/reward for our investors.
The Kos BioVentures Fund invests in early, mid and late stage private companies generated from the Greek life sciences ecosystem. We focus on innovative companies that are developing novel healthcare solutions for patients, including therapeutics, tools & diagnostics, digital health, healthcare services and healthcare & life sciences AI.
Copyright © 2024 Kos Biotechnology Partners - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.